Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
investing
6
×
life sciences
national blog main
new york blog main
san diego blog main
6
×
san diego top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
deals
fda
pfizer
president trump
alexion pharmaceuticals
bristol-myers squibb
drugs
eli lilly
What
drug
6
×
roundup
bio
alzheimer’s
annual
attention
biotech
companies
disease
plan
prices
year
advantages
ahead
ambien
american
approved
asco
assessed
attendees
bacteria
bar
biopharma
brings
business
camp’s
cancer
cash
chicago
city
clinical
combinations
communities
community’s
company
conference
days
different
digital
epidemic
Language
unset
Current search:
investing
×
drug
×
" san diego blog main "
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More